Arcadia Dialysis Center is a medicare approved dialysis facility center in Arcadia, Florida and it has 16 dialysis stations. It is located in De Soto county at 1341 E Oak St, Arcadia, FL, 34266. You can reach out to the office of Arcadia Dialysis Center at (863) 491-8550. This dialysis clinic is managed and/or owned by Davita. Arcadia Dialysis Center has the following ownership type - Profit. It was first certified by medicare in July, 1999. The medicare id for this facility is 102757 and it accepts patients under medicare ESRD program.
Name | Arcadia Dialysis Center |
---|---|
Location | 1341 E Oak St, Arcadia, Florida |
No. of Dialysis Stations | 16 |
Medicare ID | 102757 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
1341 E Oak St, Arcadia, Florida, 34266 | |
(863) 491-8550 | |
Not Available |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
NPI Number | 1093782658 |
Organization Name | Arcadia Dialysis Center |
Doing Business As | Total Renal Care Inc |
Address | 1341 E Oak St Arcadia, Florida, 34266 |
Phone Number | (863) 491-8550 |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
Dialysis patients with Hemoglobin data | 39 |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 66 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 570 |
Percentage of adult patients getting regular hemodialysis at the center | |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Arcadia Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 67 |
Hypercalcemia patient months | 580 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
Patients with Serumphosphor | 72 |
Patients with Serumphosphor less than 3.5 mg/dL | |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
Patients with Serumphosphor from 5.6 to 7 mg/dL | |
Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 58 |
Patient months included in arterial venous fistula and catheter summaries | 512 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | |
Hospitalization Rate in facility | (Not Available) |
Hospitalization Rate: Upper Confidence Limit | |
Hospitalization Rate: Lower Confidence Limit |
News Archive
Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.
WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.
Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.
A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.
Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.
› Verified 5 days ago